A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding

Journal of Hepatology

Volumn 45, Issue 4, 2006, Pages 560-567

  Villanueva, Càndid ^a   Piqueras, Marta ^a   Aracil, Carles ^a   Gómez, Cristina ^a   López Balaguer, Josep M ^a   Gonzalez, Begoña ^a   Gallego, Adolfo ^a   Torras, Xavier ^a   Soriano, Germà ^a   Sáinz, Sergio ^a   Benito, Salvador ^a   Balanzó, Joaquim ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Cirrhosis; Endoscopic therapy; Esophageal variceal bleeding; Portal hypertension; Randomized controlled trial

Indexed keywords

ISOSORBIDE MONONITRATE; NADOLOL; SOMATOSTATIN;

ACUTE DISEASE; ADULT; ARTICLE; ASPIRATION PNEUMONIA; BACTERIAL PERITONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FEVER; EMPYEMA; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS HEMORRHAGE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; LIVER CIRRHOSIS; MALE; NAUSEA; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; SEPSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; VARICOSIS; VEIN LIGATION;

ACUTE DISEASE; AGED; BLOOD PRESSURE; COMBINED MODALITY THERAPY; EMERGENCY MEDICAL SERVICES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HORMONES; HUMANS; HYPERTENSION, PORTAL; LIGATION; MALE; MIDDLE AGED; SCLEROTHERAPY; SOMATOSTATIN; SURVIVAL RATE; TREATMENT FAILURE;

EID: 33748100221     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.05.016     Document Type: Article

References (36)

1. D'Amico G., and De Franchis R. Cooperative Study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
2. Grace N.D., Groszmann R.J., Garcia-Tsao G., Burroughs A.K., Pagliaro L., Makuch R.W., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28 (1998) 868-880
3. Corley D.A., Cello J.P., Adkinsson W., Ko W.F., and Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroernterology 120 (2001) 946-954
4. D'Amico G., Pietrosi G., Tarantino I., and Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 124 (2003) 1277-1291
5. Burroughs A.K., and Patch D. Management of variceal hemorrhage in cirrhotic patients. Gut 48 (2001) 738-740
6. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33 (2000) 846-852
7. Bosch J., Abraldes J.G., and Groszmann R. Current management of portal hypertension. J Hepatol 38 (2003) S54-S68
8. Bañares R., Albillos A., Rincón D., Alonso S., González M., Ruiz-del-Arbol L., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35 (2002) 609-615
9. Villanueva C., Ortiz J., Sàbat M., Gallego A., Torras X., Soriano G., et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 30 (1999) 384-389
10. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A., Korula J., Lieberman D., Saeed Z.A., et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326 (1992) 1527-1532
11. Laine L., and Cook D. Endoscopic ligation compared with sclerothepary for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123 (1995) 280-287
12. De Franchis R., and Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 19 (1999) 439-455
13. Lo G.H., Lai K.H., Cheng J.S., Lin C.K., Huang J.S., Hsu P.I., et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 25 (1997) 1101-1104
14. Jensen D.M., Kovacs T.O.G., Randall G., Jotabha R., Freeman M., Cheng S., et al. Emergency sclerotherapy vs. rubber band ligation for actively bleeding esophageal varices in a randomized prospective study [Abstract]. Gastrointest Endosc 40 (1994) 241
15. Levacher S., Letoumelin P., Pateron D., Blaise M., Lapandry C., and Pourriat J.L. Early administration of terlipressin plus glyceryl trinatre to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346 (1995) 865-868
16. Avgerinos A, Nevens F, Raptis S, Fevery J, the ABOVE Study Group. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997;350:1495-1499.
17. Calés P., Masliah C., Bernard B., Garnier P.P., Silvain C., Szostak-Talbodec N., et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 334 (2001) 23-28
18. Abraldes J.G., and Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 35 (2002) 1305-1312
19. Soriano G., Guarner C., Tomás A., Villanueva C., Torras X., González D., et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103 (1992) 1267-1272
20. Villanueva C., Planella M., Aracil C., López-Balaguer J.M., González B., Miñana J., et al. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonreponders to the usual somatostatin dose. Am J Gastroenterol 100 (2005) 624-630
21. Sung J.K., Chung S.C., Yung M.Y., Lai C.W., Lau Y.W., Lee Y.T., et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 346 (1995) 1666-1669
22. Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices. Hepatology 22 (1995) 663-665
23. Feu F, Ruiz del Arbol L, Bañares R, Planas R, Bosch J, and members of the Variceal Bleeding Study Group. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 1996;111:1291-1299.
24. Shields R., Jenkins S.A., Baxter J.N., Kingsnorth A.N., Ellenbogen S., Makin C.A., et al. A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control oesophageal varices. J Hepatol 16 (1992) 128-137
25. Avgerinos A., Armonis A., Stefanidis G., Mathou N., Vlachogiannakos J., Kougioumtzian A., et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 39 (2004) 1623-1630
26. Ready J.B., Robertson A.D., Goff J.S., and Rector W.G. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology 100 (1991) 1403-1410
27. Moitinho E., Escorsell A., Bandi J.C., Salmerón J.M., García-Pagán J.C., Rodés J., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117 (1999) 626-631
28. Villanueva C., Ortiz J., Miñana J., Soriano G., Sàbat M., Boadas J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121 (2001) 110-117
29. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
30. Carbonell N., Pauwels A., Serfaty L., Fourdan O., Lévy V.G., and Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
31. Burroughs A.K., and McCormick P.A. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 6 (1992) 437-450
32. McCormick P.A., Jenkins S.A., McIntyre N., and Burroughs A.K. Why portal hypertensive varices bleed and bleed: a hypotesis. Gut 36 (1995) 100-103
33. Monescillo A., Marti{dotless}́nez-Lagares F., Ruiz-del-Arbol L., Sierra A., Guevara C., Jiménez E., et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40 (2004) 793-801
34. Thalheimer U., Triantos C.K., Samonakis D.N., Patch D., and Burroughs A.K. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54 (2005) 556-563
35. Bernard B., Grange J.D., Khac E.N., Amiot X., Opolon P., and Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29 (1999) 1655-1661
36. Bosch J., Thabut D., Bendtsen F., D'Amico G., Albillos A., Abraldes J.G., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130